Upward Move: Raymond Hill

Share this article:
Raymond Hill
Raymond Hill
Raymond Hill
President, inVentiv Clinical

“I turned down the position of CEO at two other companies to come here,” says Raymond Hill, the new president of inVentiv Clinical. “What brought me here was the creativity of the inVentiv Health business model. There are a lot of interesting and exciting ways to take this business.”

One avenue for moving the company forward is biotechs or, “continuum deals, which is one of the more interesting areas we're planning to play in,” Hill says. “Biotech CEOs care about two things: the best possible label and getting that label in the shortest period of time. We're the largest contract sales organization globally and a top five CRO. We can also be their commercialization partner. I'm very excited about that.”

Another goal will be adding and maintaining top talent. “Our whole value proposition is built around hiring quality people. We have to create a dynamic environment that is good for them,” he asserts. “Our average employee is 28 and a woman, and I want her to be charged up about her career.”

Hill got his start in healthcare, like many others, by accident. “I started at Booz Allen Hamilton,” he says, “early on there, I fell into a lot of pharmaceutical projects… I found it fascinating. I liked all the regulatory, technology and public policy components—and that it was a global industry.”

That fascination would stay with Hill as he moved on to other roles at A.T. Kearney and eventually to IMS Consulting Group—where he would serve as President. He would work abroad, too: running consulting services for Asia and Japan in Shanghai under IMS Health and in the U.K. where he would serve as global head of the pharmaceutical and healthcare practice for A.T. Kearney.

For those looking to distinguish themselves from their peers, Hill's advice is to “publish or present one topic every year. In your 20's, you have to carve out something that makes you unique or distinct, if you publish something once a year it's going to force you to get deep on something. That's crucial.”

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.